Our well-regarded integrated private equity practice advises private equity houses, sovereign and quasi-sovereign special opportunities funds, and other alternative asset managers, as well as senior and junior debt providers and alternative credit providers. We also have significant depth of experience in terms of advising management teams.
Transaction work is partner-led, bringing together the best specialist lawyers from multiple centres of excellence that are focused on delivering commercial pragmatic advice to complex and challenging situations.
Our private equity specialists span the private equity transaction spectrum:
We work within many industry specific sectors including healthcare, gaming, PFI, real estate and the built environment, hospitality, energy and natural resources, infrastructure, healthcare, TMT and consumer and retail.
With our 32 office locations, and through close links with over 100 firms internationally, we are able to efficiently handle cross-border transactions of any size and complexity.
Advised the management team of the Marken Group (a supply chain services provider to the pharmaceutical and life science industries) on the restructuring of its €400m LBO facilities.
Advised the management team of Mercury Pharma (a generic medicines business) on the secondary buy-out of the group by Cinven for an enterprise value of £465m.
Advised Rontec (the consortium vehicle established by Snax 24, Investec and Grovepoint Capital together with management shareholders) on its acquisition of total’s UK downstream logistics and marketing operations for £350m, and a subsequent sell-down of certain assets to Shell.